In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Oscar Health Inc (NYSE: OSCR) closed at $13.05 in the last session, up 0.31% from day before closing price of $13.01. In other words, the price has increased by $0.31 from its previous closing price. On the day, 3.56 million shares were traded. OSCR stock price reached its highest trading level at $13.28 during the session, while it also had its lowest trading level at $12.93.
Ratios:
We take a closer look at OSCR’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on March 13, 2025, Downgraded its rating to Equal Weight and sets its target price to $16 from $20 previously.
On December 10, 2024, Jefferies started tracking the stock assigning a Underperform rating and target price of $12.
BofA Securities Downgraded its Neutral to Underperform on November 06, 2024, whereas the target price for the stock was revised from $21 to $13.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 10 ’25 when ALESSANDREA QUANE bought 700 shares for $16.50 per share.
ALESSANDREA QUANE bought 5,101 shares of OSCR for $84,181 on Mar 07 ’25. On Mar 05 ’25, another insider, ALESSANDREA QUANE, who serves as the Officer of the company, bought 20,000 shares for $16.28 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OSCR now has a Market Capitalization of 3321329408 and an Enterprise Value of 1490745088. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.36 while its Price-to-Book (P/B) ratio in mrq is 3.23. Its current Enterprise Value per Revenue stands at 0.162 whereas that against EBITDA is 16.673.
Stock Price History:
The Beta on a monthly basis for OSCR is 1.75, which has changed by -0.27580464 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, OSCR has reached a high of $23.79, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -3.71%, while the 200-Day Moving Average is calculated to be -18.06%.
Shares Statistics:
According to the various share statistics, OSCR traded on average about 5.02M shares per day over the past 3-months and 4081830 shares per day over the past 10 days. A total of 214.97M shares are outstanding, with a floating share count of 177.14M. Insiders hold about 30.40% of the company’s shares, while institutions hold 63.81% stake in the company. Shares short for OSCR as of 1744675200 were 17226867 with a Short Ratio of 3.43, compared to 1741910400 on 21132664. Therefore, it implies a Short% of Shares Outstanding of 17226867 and a Short% of Float of 8.36.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 4.0 analysts. The consensus estimate for the next quarter is $0.44, with high estimates of $0.68 and low estimates of $0.29.
Analysts are recommending an EPS of between $0.88 and $0.61 for the fiscal current year, implying an average EPS of $0.73. EPS for the following year is $1.12, with 5.0 analysts recommending between $1.85 and $0.75.
Revenue Estimates
According to 7 analysts, the current quarter’s revenue is expected to be $2.87B. It ranges from a high estimate of $2.94B to a low estimate of $2.77B. As of the current estimate, Oscar Health Inc’s year-ago sales were $2.14BFor the next quarter, 7 analysts are estimating revenue of $2.78B. There is a high estimate of $2.89B for the next quarter, whereas the lowest estimate is $2.63B.
A total of 7 analysts have provided revenue estimates for OSCR’s current fiscal year. The highest revenue estimate was $11.29B, while the lowest revenue estimate was $10.59B, resulting in an average revenue estimate of $11.17B. In the same quarter a year ago, actual revenue was $9.18BBased on 7 analysts’ estimates, the company’s revenue will be $11.06B in the next fiscal year. The high estimate is $12.64B and the low estimate is $8.87B.
